Celldex Therapeutics, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $1.5 Billion | 12/24 | KRTX $12.6B |
CERE $8.2B |
RVMD $7.6B |
CYTK $5.0B |
SWTX $4.1B |
RNA $3.8B |
CRNX $3.3B |
EWTX $2.4B |
DICE $2.3B |
TVTX $2.1B |
IDYA $1.9B |
CLDX $1.5B |
DYN $1.4B |
DAWN $1.2B |
COGT $899.2M |
IMTX $605.1M |
MGTX $503.3M |
ANAB $491.4M |
KROS $413.2M |
VTYX $114.6M |
AVTE $70.7M |
ALXO $56.4M |
BCAB $24.4M |
FIXX $3.0M |
Gross Margin | 100% | 1/24 | CLDX 100% |
CYTK 100% |
KROS 100% |
RNA 100% |
IMTX 100% |
BCAB 100% |
ANAB 98% |
SWTX 93% |
DAWN 92% |
TVTX 80% |
DYN 0% |
COGT 0% |
CRNX 0% |
FIXX 0% |
IDYA 0% |
KRTX 0% |
RVMD 0% |
ALXO 0% |
CERE 0% |
EWTX 0% |
AVTE 0% |
DICE 0% |
VTYX 0% |
MGTX -10% |
Profit Margin | -100% | 18/24 | DAWN 100% |
DYN 0% |
COGT 0% |
CRNX 0% |
FIXX 0% |
IDYA 0% |
KRTX 0% |
RVMD 0% |
ALXO 0% |
BCAB 0% |
CERE 0% |
EWTX 0% |
AVTE 0% |
DICE 0% |
VTYX 0% |
IMTX -17% |
TVTX -87% |
CLDX -100% |
ANAB -100% |
CYTK -100% |
MGTX -100% |
SWTX -100% |
KROS -100% |
RNA -100% |
EBITDA margin | -1320% | 21/24 | DAWN 148% |
IMTX 2% |
ANAB -76% |
TVTX -87% |
DYN -100% |
COGT -100% |
CRNX -100% |
FIXX -100% |
IDYA -100% |
KRTX -100% |
RVMD -100% |
ALXO -100% |
CERE -100% |
EWTX -100% |
AVTE -100% |
DICE -100% |
VTYX -100% |
BCAB -102% |
SWTX -118% |
MGTX -367% |
CLDX -1320% |
RNA -4171% |
KROS -15118% |
CYTK -29859% |
Quarterly Revenue | $3.2 Million | 8/24 | TVTX $62.9M |
IMTX $55.6M |
SWTX $49.3M |
ANAB $30.0M |
DAWN $20.1M |
BCAB $11.0M |
MGTX $10.9M |
CLDX $3.2M |
RNA $2.3M |
CYTK $463,000 |
KROS $388,000 |
DYN $0 |
COGT $0 |
CRNX $0 |
FIXX $0 |
IDYA $0 |
KRTX $0 |
RVMD $0 |
ALXO $0 |
CERE $0 |
EWTX $0 |
AVTE $0 |
DICE $0 |
VTYX $0 |
Quarterly Earnings | -$42.1 Million | 12/24 | DAWN $37.0M |
FIXX $1.0M |
BCAB -$0 |
IMTX -$9.4M |
AVTE -$16.2M |
ALXO -$30.7M |
ANAB -$32.9M |
EWTX -$34.1M |
DICE -$34.8M |
VTYX -$35.2M |
MGTX -$39.3M |
CLDX -$42.1M |
IDYA -$51.8M |
KROS -$53.0M |
SWTX -$53.5M |
TVTX -$54.8M |
COGT -$70.6M |
CRNX -$76.8M |
RNA -$80.4M |
DYN -$97.1M |
KRTX -$113.8M |
CERE -$131.9M |
RVMD -$156.3M |
CYTK -$160.5M |
Quarterly Free Cash Flow | -$54.7 Million | 17/24 | DAWN -$5.0M |
BCAB -$5.1M |
ANAB -$10.1M |
FIXX -$14.6M |
SWTX -$16.0M |
AVTE -$16.0M |
MGTX -$22.0M |
TVTX -$23.8M |
ALXO -$25.5M |
EWTX -$27.9M |
DICE -$30.4M |
KROS -$30.9M |
VTYX -$35.5M |
IMTX -$40.1M |
IDYA -$49.7M |
COGT -$52.3M |
CLDX -$54.7M |
CRNX -$63.4M |
RNA -$67.3M |
DYN -$74.9M |
CYTK -$104.0M |
KRTX -$111.9M |
CERE -$119.9M |
RVMD -$133.9M |
Trailing 4 Quarters Revenue | $10.0 Million | 9/24 | TVTX $203.4M |
SWTX $135.5M |
IMTX $127.2M |
ANAB $57.2M |
DAWN $28.8M |
MGTX $13.9M |
BCAB $11.0M |
RNA $10.1M |
CLDX $10.0M |
IDYA $3.9M |
DYN $3.8M |
CYTK $3.2M |
CRNX $1.0M |
KRTX $654,000 |
KROS $651,000 |
FIXX $354,000 |
COGT $0 |
RVMD $0 |
ALXO $0 |
CERE $0 |
EWTX $0 |
AVTE $0 |
DICE $0 |
VTYX $0 |
Trailing 4 Quarters Earnings | -$161.0 Million | 11/24 | TVTX $62.9M |
IMTX $55.6M |
SWTX $49.3M |
ANAB $30.0M |
DAWN $20.1M |
BCAB $11.0M |
MGTX $10.9M |
CLDX $3.2M |
RNA $2.3M |
CYTK $463,000 |
KROS $388,000 |
DYN -$0 |
COGT -$0 |
CRNX -$0 |
FIXX -$0 |
IDYA -$0 |
KRTX -$0 |
RVMD -$0 |
ALXO -$0 |
CERE -$0 |
EWTX -$0 |
AVTE -$0 |
DICE -$0 |
VTYX -$0 |
Quarterly Earnings Growth | -10% | 12/24 | DAWN 180% |
FIXX 104% |
IMTX 68% |
ALXO 40% |
VTYX 35% |
SWTX 33% |
AVTE 17% |
ANAB 12% |
MGTX 11% |
RVMD 9% |
BCAB 0% |
CLDX -10% |
CYTK -24% |
CERE -26% |
COGT -28% |
EWTX -33% |
CRNX -34% |
KROS -34% |
KRTX -49% |
RNA -54% |
DYN -61% |
DICE -62% |
IDYA -89% |
TVTX -136% |
Annual Earnings Growth | -24% | 16/24 | VTYX 51% |
DAWN 50% |
IMTX 44% |
FIXX 35% |
MGTX 34% |
BCAB 34% |
SWTX 12% |
ALXO 2% |
ANAB -6% |
AVTE -10% |
CYTK -12% |
DYN -16% |
RVMD -16% |
KROS -19% |
CERE -20% |
CLDX -24% |
DICE -26% |
COGT -29% |
CRNX -32% |
KRTX -37% |
EWTX -38% |
RNA -45% |
IDYA -60% |
TVTX -231% |
Quarterly Revenue Growth | 110% | 6/24 | KROS 4750% |
ANAB 805% |
SWTX 783% |
IMTX 753% |
MGTX 114% |
CLDX 110% |
TVTX 70% |
CYTK 22% |
DYN 0% |
COGT 0% |
ALXO 0% |
BCAB 0% |
CERE 0% |
EWTX 0% |
AVTE 0% |
DAWN 0% |
DICE 0% |
VTYX 0% |
RNA -17% |
CRNX -100% |
FIXX -100% |
IDYA -100% |
KRTX -100% |
RVMD -100% |
Annual Revenue Growth | 330% | 3/24 | KROS 8038% |
SWTX 487% |
CLDX 330% |
ANAB 317% |
MGTX 173% |
IMTX 59% |
CYTK 8% |
RNA 4% |
DYN 0% |
COGT 0% |
ALXO 0% |
BCAB 0% |
CERE 0% |
EWTX 0% |
AVTE 0% |
DAWN 0% |
DICE 0% |
VTYX 0% |
TVTX -6% |
CRNX -69% |
IDYA -79% |
KRTX -88% |
FIXX -89% |
RVMD -100% |
Cash On Hand | $36.4 Million | 22/24 | DYN $532.2M |
KROS $530.7M |
DAWN $422.8M |
IDYA $400.3M |
RNA $370.2M |
CERE $320.4M |
CRNX $317.3M |
IMTX $207.9M |
RVMD $201.3M |
ANAB $191.6M |
KRTX $185.8M |
MGTX $122.9M |
FIXX $115.5M |
COGT $97.0M |
SWTX $84.5M |
DICE $73.5M |
VTYX $61.8M |
BCAB $56.5M |
CYTK $46.9M |
EWTX $44.8M |
TVTX $36.4M |
CLDX $36.4M |
AVTE $31.1M |
ALXO $16.1M |
Short Term Debt | $1.4 Million | 16/24 | TVTX $73.9M |
CYTK $30.4M |
RVMD $8.4M |
CRNX $7.4M |
DYN $4.8M |
MGTX $4.2M |
RNA $3.8M |
CERE $3.5M |
IMTX $3.1M |
FIXX $3.1M |
KRTX $2.8M |
ANAB $1.9M |
KROS $1.9M |
DICE $1.5M |
COGT $1.5M |
CLDX $1.4M |
BCAB $1.3M |
SWTX $1.2M |
VTYX $1.0M |
EWTX $992,000 |
AVTE $459,000 |
DAWN $77,000 |
IDYA -$0 |
ALXO -$0 |
Long Term Debt | $1.7 Million | 21/24 | CYTK $759.3M |
CERE $364.8M |
TVTX $328.5M |
RVMD $78.3M |
CRNX $45.1M |
IDYA $37.6M |
DYN $20.0M |
KROS $17.4M |
COGT $16.3M |
ANAB $14.6M |
IMTX $14.5M |
KRTX $13.8M |
DICE $11.0M |
VTYX $10.0M |
ALXO $9.8M |
FIXX $6.1M |
SWTX $5.7M |
RNA $3.8M |
EWTX $3.4M |
DAWN $2.5M |
CLDX $1.7M |
AVTE $81,000 |
MGTX $0 |
BCAB $0 |
PE | -1.00 | 1/24 | CLDX -1.00 |
DYN -1.00 |
ANAB -1.00 |
COGT -1.00 |
CYTK -1.00 |
CRNX -1.00 |
FIXX -1.00 |
IDYA -1.00 |
KRTX -1.00 |
MGTX -1.00 |
RVMD -1.00 |
SWTX -1.00 |
KROS -1.00 |
RNA -1.00 |
IMTX -1.00 |
ALXO -1.00 |
BCAB -1.00 |
CERE -1.00 |
EWTX -1.00 |
AVTE -1.00 |
TVTX -1.00 |
DAWN -1.00 |
DICE -1.00 |
VTYX -1.00 |
PS | 148.04 | 8/24 | KRTX 19264.95 |
CRNX 3142.72 |
CYTK 1546.39 |
KROS 634.68 |
IDYA 483.60 |
RNA 375.37 |
DYN 373.97 |
CLDX 148.04 |
DAWN 42.44 |
MGTX 36.13 |
SWTX 30.27 |
TVTX 10.16 |
ANAB 8.60 |
FIXX 8.48 |
IMTX 4.33 |
BCAB 2.22 |
COGT -1.00 |
RVMD -1.00 |
ALXO -1.00 |
CERE -1.00 |
EWTX -1.00 |
AVTE -1.00 |
DICE -1.00 |
VTYX -1.00 |
PB | 1.88 | 14/24 | CERE 14.51 |
KRTX 10.05 |
SWTX 7.70 |
ANAB 5.82 |
MGTX 5.26 |
EWTX 5.01 |
RVMD 4.83 |
DICE 4.37 |
CRNX 3.92 |
COGT 2.86 |
RNA 2.53 |
DAWN 2.20 |
DYN 2.01 |
CLDX 1.88 |
IDYA 1.61 |
IMTX 1.44 |
BCAB 1.06 |
AVTE 0.88 |
KROS 0.78 |
ALXO 0.41 |
VTYX 0.41 |
FIXX 0.06 |
CYTK 0.00 |
TVTX 0.00 |
PC | 40.57 | 6/24 | CYTK 106.16 |
KRTX 67.80 |
TVTX 56.77 |
EWTX 54.63 |
SWTX 48.56 |
CLDX 40.57 |
RVMD 37.56 |
DICE 30.91 |
CERE 25.56 |
CRNX 10.29 |
RNA 10.26 |
COGT 9.27 |
IDYA 4.74 |
MGTX 4.10 |
ALXO 3.50 |
IMTX 2.91 |
DAWN 2.89 |
DYN 2.66 |
ANAB 2.57 |
AVTE 2.27 |
VTYX 1.85 |
KROS 0.78 |
BCAB 0.43 |
FIXX 0.03 |
Liabilities to Equity | 0.05 | 20/24 | ANAB 4.85 |
MGTX 2.13 |
FIXX 2.12 |
BCAB 1.71 |
CERE 1.00 |
IMTX 0.51 |
ALXO 0.36 |
COGT 0.22 |
SWTX 0.14 |
CRNX 0.13 |
RVMD 0.13 |
AVTE 0.13 |
DYN 0.09 |
KROS 0.09 |
RNA 0.09 |
DAWN 0.08 |
VTYX 0.08 |
KRTX 0.07 |
DICE 0.06 |
CLDX 0.05 |
IDYA 0.05 |
EWTX 0.05 |
CYTK 0.00 |
TVTX 0.00 |
ROA | -0.20 | 6/24 | IMTX -11% | IDYA -14% | DAWN -15% | RNA -17% | DICE -18% | CLDX -20% | EWTX -24% | MGTX -29% | CRNX -30% | RVMD -31% | KROS -31% | KRTX -32% | ANAB -34% | VTYX -35% | DYN -39% | CYTK -40% | CERE -41% | SWTX -45% | FIXX -55% | COGT -63% | TVTX -70% | ALXO -81% | AVTE -93% | BCAB -114% |
ROE | -0.20 | 8/24 | CYTK 4143% |
TVTX 1154% |
IDYA -15% |
IMTX -16% |
DAWN -16% |
RNA -19% |
DICE -19% |
CLDX -20% |
EWTX -25% |
CRNX -33% |
KRTX -34% |
RVMD -34% |
KROS -34% |
VTYX -38% |
DYN -42% |
SWTX -52% |
COGT -77% |
CERE -82% |
MGTX -92% |
AVTE -105% |
ALXO -110% |
FIXX -170% |
ANAB -196% |
BCAB -310% |
Current Ratio | 22.08 | 2/24 | EWTX 22.82 |
CLDX 22.08 |
IDYA 20.85 |
DICE 17.42 |
KRTX 16.30 |
VTYX 13.49 |
DAWN 13.25 |
KROS 12.47 |
DYN 12.15 |
RNA 11.94 |
CRNX 8.98 |
RVMD 8.96 |
AVTE 8.69 |
SWTX 7.98 |
COGT 5.54 |
ALXO 3.80 |
IMTX 2.96 |
CERE 2.00 |
BCAB 1.58 |
FIXX 1.47 |
MGTX 1.47 |
ANAB 1.21 |
CYTK 0.99 |
TVTX 0.94 |
Quick Ratio | 20.28 | 2/24 | CLDX -1.00 |
DYN -1.00 |
ANAB -1.00 |
COGT -1.00 |
CYTK -1.00 |
CRNX -1.00 |
FIXX -1.00 |
IDYA -1.00 |
KRTX -1.00 |
MGTX -1.00 |
RVMD -1.00 |
SWTX -1.00 |
KROS -1.00 |
RNA -1.00 |
IMTX -1.00 |
ALXO -1.00 |
BCAB -1.00 |
CERE -1.00 |
EWTX -1.00 |
AVTE -1.00 |
TVTX -1.00 |
DAWN -1.00 |
DICE -1.00 |
VTYX -1.00 |
Long Term Debt to Equity | 0.00 | 17/24 | CERE} 0.65 |
ANAB} 0.17 |
FIXX} 0.13 |
ALXO} 0.07 |
COGT} 0.05 |
CRNX} 0.05 |
RVMD} 0.05 |
VTYX} 0.04 |
DYN} 0.03 |
IDYA} 0.03 |
KROS} 0.03 |
IMTX} 0.03 |
DICE} 0.02 |
KRTX} 0.01 |
SWTX} 0.01 |
EWTX} 0.01 |
CLDX} 0.00 |
MGTX} 0.00 |
RNA} 0.00 |
BCAB} 0.00 |
AVTE} 0.00 |
DAWN} 0.00 |
TVTX} -10.79 |
CYTK} -54.58 |
Debt to Equity | 0.00 | 21/24 | CERE 0.65 |
ANAB 0.20 |
FIXX 0.19 |
ALXO 0.07 |
COGT 0.06 |
CRNX 0.06 |
RVMD 0.06 |
BCAB 0.05 |
DYN 0.04 |
MGTX 0.04 |
KROS 0.04 |
IMTX 0.04 |
VTYX 0.04 |
IDYA 0.02 |
DICE 0.02 |
KRTX 0.01 |
SWTX 0.01 |
RNA 0.01 |
EWTX 0.01 |
AVTE 0.01 |
CLDX 0.00 |
DAWN 0.00 |
TVTX -13.21 |
CYTK -48.51 |
Burn Rate | 0.86 | 18/24 | IMTX 17.76 |
KROS 9.81 |
IDYA 7.51 |
ANAB 5.65 |
DYN 5.37 |
RNA 4.54 |
CRNX 3.94 |
MGTX 3.04 |
CERE 2.17 |
DICE 2.06 |
AVTE 1.90 |
VTYX 1.72 |
KRTX 1.61 |
SWTX 1.56 |
COGT 1.35 |
EWTX 1.30 |
RVMD 1.25 |
CLDX 0.86 |
ALXO 0.52 |
TVTX 0.42 |
CYTK 0.24 |
BCAB -1.00 |
DAWN -11.45 |
FIXX -8858.05 |
Cash to Cap | 0.02 | 19/24 | FIXX 38.46 |
BCAB 2.32 |
KROS 1.28 |
VTYX 0.54 |
AVTE 0.44 |
ANAB 0.39 |
DYN 0.38 |
DAWN 0.35 |
IMTX 0.34 |
ALXO 0.29 |
MGTX 0.24 |
IDYA 0.21 |
COGT 0.11 |
CRNX 0.10 |
RNA 0.10 |
CERE 0.04 |
RVMD 0.03 |
DICE 0.03 |
CLDX 0.02 |
SWTX 0.02 |
EWTX 0.02 |
TVTX 0.02 |
CYTK 0.01 |
KRTX 0.01 |
CCR | 1.30 | 2/24 | IMTX 4.26 |
CLDX 1.30 |
VTYX 1.01 |
AVTE 0.99 |
KRTX 0.98 |
IDYA 0.96 |
CERE 0.91 |
DICE 0.87 |
RVMD 0.86 |
RNA 0.84 |
ALXO 0.83 |
CRNX 0.82 |
EWTX 0.82 |
DYN 0.77 |
COGT 0.74 |
CYTK 0.65 |
KROS 0.58 |
MGTX 0.56 |
TVTX 0.43 |
ANAB 0.31 |
SWTX 0.30 |
DAWN -0.13 |
BCAB -1.00 |
FIXX -14.14 |
EV to EBITDA | -34.27 | 19/24 | IMTX} 537.49 |
DAWN} 27.10 |
FIXX} 6.96 |
BCAB} 2.74 |
KROS} 1.67 |
COGT} -1.00 |
RVMD} -1.00 |
ALXO} -1.00 |
CERE} -1.00 |
EWTX} -1.00 |
AVTE} -1.00 |
DICE} -1.00 |
VTYX} -1.00 |
DYN} -8.64 |
MGTX} -9.61 |
ANAB} -13.90 |
IDYA} -22.66 |
CRNX} -34.18 |
CLDX} -34.27 |
RNA} -35.26 |
CYTK} -40.55 |
TVTX} -44.44 |
SWTX} -69.44 |
KRTX} -96.25 |
EV to Revenue | 144.70 | 7/24 | KRTX 19006.33 |
CRNX 2887.93 |
CYTK 1741.48 |
IDYA 386.36 |
RNA 339.53 |
DYN 240.04 |
CLDX 144.70 |
SWTX 29.70 |
DAWN 27.86 |
MGTX 27.61 |
TVTX 11.96 |
ANAB 5.53 |
IMTX 3.87 |
COGT -1.00 |
RVMD -1.00 |
ALXO -1.00 |
CERE -1.00 |
EWTX -1.00 |
AVTE -1.00 |
DICE -1.00 |
VTYX -1.00 |
BCAB -2.81 |
KROS -150.88 |
FIXX -291.86 |